Baker Hughes Reports 11% Rise in Q4 Adjusted Profit Driven by LNG Demand 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Annual General Shareholders' Meeting of May 10, 2017
- Shareholders' approval of the financial statements for 2016 -
- Dividend of €2.96 per share payable as of May 18, 2017 -
- Board Composition: renewal and appointments -
Paris, France - May 10, 2017 - The Combined General Shareholders' Meeting of Sanofi was held today at the Palais des Congrès in Paris under the chairmanship of Serge Weinberg. All resolutions submitted to the vote were adopted by its shareholders.
The shareholders approved, among other resolutions, the individual Company and consolidated financial statements for the year 2016. At the General Meeting, shareholders decided the distribution of a cash dividend in the amount of € 2.96 per share with payment as of May 18, 2017.
The General Meeting also renewed as Director Fabienne Lecorvaisier and approved the appointment of Bernard Charlès and Melanie Lee as independent Directors, for a term of four years, i.e., until the General Meeting called to approve the financial statements for the year 2020.
Following the General Meeting, the new Board of Directors is comprised of 14 members, of whom six are women. A large majority of the Board's Directors is independent
- Serge Weinberg*, Chairman of the Board of Directors
- Olivier Brandicourt, Chief Executive Officer
- Laurent Attal
- Robert Castaigne*
- Bernard Charlès*
- Claudie Haigneré*
- Patrick Kron*
- Fabienne Lecorvaisier*
- Melanie Lee*
- Suet-Fern Lee*
- Christian Mulliez
- Carole Piwnica*
- Diane Souza*
- Thomas Südhof*
The composition of the committees remains unchanged.
The voting results will be available on the Company's website (www.sanofi.com) in the coming days.
The audiocast of the Annual General Shareholder Meeting is available on the Company's website (www.sanofi.com).
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Contacts:
| Relations Presse Laurence Bollack + (33) 1 53 77 46 46 [email protected] | Relations Investisseurs George Grofik + (33) 1 53 77 45 45 [email protected] |
(* Independent Director)
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/51edbdd2-14e5-4db4-9da7-c2241639ea4c
